Kangmei Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Kangmei Pharmaceutical Co Ltd cash flow reinvestment rate. Kangmei Pharmaceutical Co Ltd (600518) has a Cash Flow Reinvestment Rate of 0.22x as of September 2025, reinvesting CN¥48.57 Million (capex CN¥48.57 Million ) from operating cash flow of CN¥219.96 Million. Explore 600518 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Kangmei Pharmaceutical Co Ltd (1999–2021)
Cash flow reinvestment rate of Kangmei Pharmaceutical Co Ltd from 1999 to 2021. Historical reinvestment intensity for Kangmei Pharmaceutical Co Ltd across 22 annual periods. Explore Kangmei Pharmaceutical Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Kangmei Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (1999–2021)
Kangmei Pharmaceutical Co Ltd cash flow reinvestment rate by year from 1999 to 2021. Year-by-year capital reinvestment analysis for Kangmei Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see how efficiently does Kangmei Pharmaceutical Co Ltd generate cash.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.80x | CN¥171.64 Million | CN¥214.21 Million | CN¥171.63 Million | ▲ +173.9% |
| 2020 | 0.29x | CN¥301.74 Million | CN¥1.03 Billion | CN¥301.73 Million | ▲ +7.2% |
| 2019 | 0.27x | CN¥786.25 Million | CN¥2.88 Billion | CN¥473.20 Million | ▼ -98.2% |
| 2018 | 15.06x | CN¥4.60 Billion | CN¥305.62 Million | CN¥4.59 Billion | ▲ +1429.0% |
| 2016 | 0.99x | CN¥1.58 Billion | CN¥1.60 Billion | CN¥1.57 Billion | ▼ -63.8% |
| 2015 | 2.73x | CN¥1.39 Billion | CN¥508.86 Million | CN¥1.37 Billion | ▲ +352.4% |
| 2014 | 0.60x | CN¥682.06 Million | CN¥1.13 Billion | CN¥682.06 Million | ▲ +43.4% |
| 2013 | 0.42x | CN¥703.43 Million | CN¥1.67 Billion | CN¥703.43 Million | ▼ -69.8% |
| 2012 | 1.39x | CN¥1.41 Billion | CN¥1.01 Billion | CN¥1.41 Billion | ▼ -65.5% |
| 2011 | 4.04x | CN¥2.32 Billion | CN¥574.96 Million | CN¥2.32 Billion | ▲ +251.7% |
| 2010 | 1.15x | CN¥768.02 Million | CN¥669.19 Million | CN¥768.02 Million | ▼ -81.1% |
| 2009 | 6.06x | CN¥724.25 Million | CN¥119.47 Million | CN¥724.25 Million | ▼ -97.4% |
| 2008 | 229.90x | CN¥693.14 Million | CN¥3.02 Million | CN¥693.14 Million | ▲ +11285.6% |
| 2007 | 2.02x | CN¥328.23 Million | CN¥162.55 Million | CN¥328.23 Million | ▼ -66.6% |
| 2006 | 6.05x | CN¥413.45 Million | CN¥68.32 Million | CN¥413.45 Million | ▲ +3496.3% |
| 2005 | 0.17x | CN¥22.40 Million | CN¥133.13 Million | CN¥22.40 Million | ▼ -91.2% |
| 2004 | 1.91x | CN¥150.20 Million | CN¥78.52 Million | CN¥150.20 Million | ▲ +206.9% |
| 2003 | 0.62x | CN¥48.63 Million | CN¥78.02 Million | CN¥48.63 Million | ▼ -83.5% |
| 2002 | 3.79x | CN¥202.41 Million | CN¥53.47 Million | CN¥202.41 Million | ▼ -49.0% |
| 2001 | 7.43x | CN¥116.54 Million | CN¥15.69 Million | CN¥116.54 Million | ▲ +4442.5% |
| 2000 | 0.16x | CN¥1.63 Million | CN¥9.96 Million | CN¥1.63 Million | ▼ -61.8% |
| 1999 | 0.43x | CN¥12.96 Million | CN¥30.25 Million | CN¥12.96 Million | — |